Corneal Collagen Crosslinking with Riboflavin (CXL) is a technique that was first used in 1998 to treat patients with a disease called keratoconus. In keratoconus the cornea (the front clear window of the eye) becomes weak, thin, and irregularly shaped. CXL is now being performed for patients with this condition at nearly 400 centers throughout the world. Through a research study, CXL USA is now able to provide this breakthrough investigational treatment to our patients using this unique advanced technology.
At the Center for Excellence in Eye Care, we offer a variety of payment options. Our goal is to help our clients with their medical eye care needs, which is why we offer financing options through CareCredit.
© Copyright 2017 Center For Excellence in Eyecare. All Rights Reserved. Medical website by Glacial Multimedia